2021 Classic Lectures in Pathology: What You Need to Know: Breast Pathology - A Video CME Teaching Activity
AMA PRA Category 1 Credit(s)™:
6.75
Category A CE Credits:
About this CME Teaching Activity
This CME Activity offers a practical review of breast pathology combining basic to advanced techniques, pearls and pitfalls to pathologic diagnosis and case reviews.
CLPBV21
About This CME Teaching Activity
This CME Activity offers a practical review of breast pathology combining basic to advanced techniques, pearls and pitfalls to pathologic diagnosis and case reviews.
Target Audience
This CME activity is intended and designed to educate pathologists.
Educational Objectives
At the completion of this CME teaching activity, you should be able to:
-
Explain the spectrum of benign spindle cell lesions in the breast.
-
Describe sclerosing lesions of the breast.
-
Identify key features of genomic testing in breast cancer diagnosis and treatment planning.
-
Discuss breast cancer predictive factor testing (ER, PR & HER2).
-
Describe the diagnostic features and clinical significance of a v ariety of breast lesions with particular reference to the implications of these diagnoses in core needle biopsy specimens.
No special educational preparation is required for this CME activity.
USB & DVD Cancellation Policy: Return within 15 days of receiving - No refunds after. $125.00 processing fee for each series. Shipping non-refundable. Cancellations must be in writing. No CME credit on returned purchases. 2+ returns voids cancellation policy.
On-Demand Cancellation Policy: We offer a free trial period. Please use the evaluation period to ensure your online system meets the requirements necessary to view. If you are not satisfied, you may receive a refund within 90 days if you have watched less than 20% of your purchase.
Scientific Sponsor
Educational Symposia
Accreditation
Physicians: Educational Symposia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Educational Symposia designates this enduring material for a maximum of 6.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All activity participants are required to take a written or online test in order to be awarded credit. (Exam materials, if ordered, will be sent with your order.) All course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives.
AMA PRA Category 1 Credit(s)TM for these programs may be claimed until January 14, 2024.
This CME activity was planned and produced by Educational Symposia, a leader in continuing medical education since 1975.
This activity was planned and produced in accordance with the ACCME Essential Areas and Elements.
David G. Hicks, M.D.
Professor, Department of Pathology and Laboratory Medicine
Director, Surgical Pathology Unit
University of Rochester Medical Center
Rochester, NY
Christopher D.M. Fletcher, M.D., FRCPath
Vice-Chair for Anatomic Pathology, Brigham & Women’s Hospital
Chief of Onco-Pathology, Dana-Farber Cancer Institute
Professor of Pathology, Harvard Medical School
Boston, MA
Charles D. Sturgis, M.D.
Staff Cytopathologist
R.J. Tomsich Pathology & Lab Medicine Institute
Cleveland Clinic
Associate Professor of Pathology
Cleveland Clinic Lerner College of Medicine of
Case Western Reserve University
Cleveland, OH
Session 1
Ductal Carcinoma In Situ of Breast: Updates and Differential Diagnoses
Charles D. Sturgis, M.D.
Spindle Cell and Vascular Lesions of Breast
Christopher D.M. Fletcher, M.D., FRCPath
Session 2
Benign Breast Disease: Atypical Proliferative Lesion: Diagnosis and Breast Cancer Risk
David G. Hicks, M.D.
Sclerosing Lesions of the Breast
David G. Hicks, M.D.
Session 3
Genomic in Breast Cancer Diagnosis and Treatment Planning: Is this an Opportunity to Enhance the Role of Pathologists in Multidisciplinary Care?
David G. Hicks, M.D.
Breast Cancer Predictive Factor Testing (ER, PR & HER2): Bridging the Gap Between Diagnosis and Management
David G. Hicks, M.D.
Session 4
Ancillary Breast Cancer Studies: Rogue Cases, Challenges, Pitfalls and Trouble Shooting
David G. Hicks, M.D.
Challenging Breast Pathology Case Studies
David G. Hicks, M.D.